Mr. Perfecto Cruz Valarao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1716 Harford Rd, Suite 101, Fallston, MD 21047 Phone: 410-879-7100 Fax: 410-877-7222 |
Dr. Roger W Marcus, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1814 Bel Air Rd, Fallston, MD 21047 Phone: 410-877-0271 Fax: 410-877-0274 |
Dr. Thomas Francis Burke, M.D. Internal Medicine - Sleep Medicine Medicare: Not Enrolled in Medicare Practice Location: 2303 Bel Air Rd, C/o Sleepmed, Fallston, MD 21047 Phone: 443-453-5055 Fax: 443-453-5054 |
News Archive
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
PTSD can occur after any kind of experience that causes trauma, whether that be in war, after a natural disaster or because of child abuse or sexual assault. Symptoms can include flashbacks, feeling emotionally numb or hyper-alert to danger, and avoiding situations that act as reminders of the original trauma. It is estimated that up to 3% of the general population is likely to be affected by PTSD at some point.
Steve A.N. Goldstein and colleagues from the Pritzker School of Medicine in Chicago have found that a specific mutation, called S1103Y, in a heart protein known as SCN5A is associated with a dramatic, 24-fold increased risk of sudden infant death syndrome (SIDS) in African American infants.
China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines in China, today announced financial results for the three months ended July 31, 2011.
› Verified 1 days ago